These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 39105636)

  • 1. Design, synthesis, molecular modeling, in vitro evaluation of novel piperidine-containing hydrazone derivatives as cholinesterase inhibitors.
    Tok F; Baltaş N; Abas Bİ; Tatar Yılmaz G; Kaya S; Koçyiğit-Kaymakçıoğlu B; Çevik Ö
    Drug Dev Res; 2024 Aug; 85(5):e22240. PubMed ID: 39105636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
    Karaman N; Sıcak Y; Taşkın-Tok T; Öztürk M; Karaküçük-İyidoğan A; Dikmen M; Koçyiğit-Kaymakçıoğlu B; Oruç-Emre EE
    Eur J Med Chem; 2016 Nov; 124():270-283. PubMed ID: 27592396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies.
    Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M
    Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, bioactivity and molecular modeling studies on potential anti-Alzheimer piperidinehydrazide-hydrazones.
    Parlar S; Sayar G; Tarikogullari AH; Karadagli SS; Alptuzun V; Erciyas E; Holzgrabe U
    Bioorg Chem; 2019 Jun; 87():888-900. PubMed ID: 30538051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imidazole-thiadiazole hybrids: A multitarget de novo drug design approach, in vitro evaluation, ADME/T, and in silico studies.
    Maqbool M; Solangi M; Khan KM; Özil M; Baltaş N; Salar U; Tariq SS; Haq ZU; Taha M
    Arch Pharm (Weinheim); 2024 Sep; 357(9):e2400325. PubMed ID: 38885529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine-1,4-dione derivatives as anti-Alzheimer's agents.
    Nuha D; Evren AE; Özkan BNS; Gundogdu-Karaburun N; Karaburun AÇ
    Arch Pharm (Weinheim); 2024 Oct; 357(10):e2400067. PubMed ID: 38967191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Substituted piperidine-3-carbohydrazide-hydrazones against Alzheimer's disease: Synthesis and evaluation of cholinesterase, beta-amyloid inhibitory activity, and antioxidant capacity.
    Parlar S; Sayar G; Tarikogullari AH; Karadagli SS; Alan E; Sevin G; Erciyas E; Holzgrabe U; Alptuzun V
    Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200519. PubMed ID: 36461719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
    Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
    Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
    Parlar S; Bayraktar G; Tarikogullari AH; Alptüzün V; Erciyas E
    Chem Pharm Bull (Tokyo); 2016; 64(9):1281-7. PubMed ID: 27581632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactive sulfonyl hydrazones with alkyl derivative: Characterization, ADME properties, molecular docking studies and investigation of inhibition on choline esterase enzymes for the diagnosis of Alzheimer's disease.
    Bilen E; Özdemir Özmen Ü; Çete S; Alyar S; Yaşar A
    Chem Biol Interact; 2022 Jun; 360():109956. PubMed ID: 35452634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, molecular docking studies, and biological evaluation of novel alkyl bis(4-amino-5-cyanopyrimidine) derivatives.
    Boualia I; Derabli C; Boulcina R; Bensouici C; Yildirim M; Birinci Yildirim A; Mokrani EH; Debache A
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900027. PubMed ID: 31448454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
    Singh YP; Shankar G; Jahan S; Singh G; Kumar N; Barik A; Upadhyay P; Singh L; Kamble K; Singh GK; Tiwari S; Garg P; Gupta S; Modi G
    Bioorg Med Chem; 2021 Sep; 46():116385. PubMed ID: 34481338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, and Biological Evaluation of Novel Indanone Derivatives as Cholinesterase Inhibitors for Potential Use in Alzheimer's Disease.
    Etemadi A; Hemmati S; Shahrivar-Gargari M; Abibiglue YT; Bavili A; Hamzeh-Mivehroud M; Dastmalchi S
    Chem Biodivers; 2023 Aug; 20(8):e202300075. PubMed ID: 37458518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Cholinesterase, α-Glucosidase Inhibitory, Antioxidant, Molecular Docking, and Kinetic Studies on Potent Succinimide Derivatives.
    Ahmad A; Ullah F; Sadiq A; Ayaz M; Saeed Jan M; Shahid M; Wadood A; Mahmood F; Rashid U; Ullah R; Sahibzada MUK; Alqahtani AS; Mahmood HM
    Drug Des Devel Ther; 2020; 14():2165-2178. PubMed ID: 32606589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, in silico and in vitro studies of hydrazide-hydrazone imine derivatives as potential cholinesterase inhibitors.
    Güngör SA
    Chem Biol Drug Des; 2023 Oct; 102(4):676-691. PubMed ID: 37258044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Kovaleva NV; Yu Astakhova T; Boltneva NP; Rudakova EV; Serebryakova OG; Proshin AN; Serkov IV; Trofimova TP; Tafeenko VA; Radchenko EV; Palyulin VA; Fisenko VP; Korábečný J; Soukup O; Richardson RJ
    Bioorg Chem; 2021 Jul; 112():104974. PubMed ID: 34029971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
    Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
    Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro.
    Utku S; Gökçe M; Orhan I; Sahin MF
    Arzneimittelforschung; 2011; 61(1):1-7. PubMed ID: 21355440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel multifunctional tacrine-donepezil hybrids against Alzheimer's disease: Design synthesis and bioactivity studies.
    Bayraktar G; Bartolini M; Bolognesi ML; Erdoğan MA; Armağan G; Bayır E; Şendemir A; Bagetta D; Alcaro S; Alptüzün V
    Arch Pharm (Weinheim); 2024 Jul; 357(7):e2300575. PubMed ID: 38593283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.